全文获取类型
收费全文 | 210256篇 |
免费 | 15211篇 |
国内免费 | 749篇 |
专业分类
耳鼻咽喉 | 2284篇 |
儿科学 | 5482篇 |
妇产科学 | 4304篇 |
基础医学 | 27098篇 |
口腔科学 | 4512篇 |
临床医学 | 19997篇 |
内科学 | 44881篇 |
皮肤病学 | 2754篇 |
神经病学 | 20303篇 |
特种医学 | 6951篇 |
外国民族医学 | 13篇 |
外科学 | 32913篇 |
综合类 | 3411篇 |
现状与发展 | 2篇 |
一般理论 | 291篇 |
预防医学 | 19062篇 |
眼科学 | 4373篇 |
药学 | 14387篇 |
1篇 | |
中国医学 | 374篇 |
肿瘤学 | 12823篇 |
出版年
2023年 | 843篇 |
2022年 | 1405篇 |
2021年 | 3440篇 |
2020年 | 2105篇 |
2019年 | 3390篇 |
2018年 | 3967篇 |
2017年 | 3212篇 |
2016年 | 3410篇 |
2015年 | 4066篇 |
2014年 | 6095篇 |
2013年 | 8822篇 |
2012年 | 13123篇 |
2011年 | 14319篇 |
2010年 | 8096篇 |
2009年 | 7304篇 |
2008年 | 13588篇 |
2007年 | 14424篇 |
2006年 | 13918篇 |
2005年 | 14392篇 |
2004年 | 13806篇 |
2003年 | 12899篇 |
2002年 | 12435篇 |
2001年 | 1873篇 |
2000年 | 1457篇 |
1999年 | 2045篇 |
1998年 | 2828篇 |
1997年 | 2437篇 |
1996年 | 2205篇 |
1995年 | 1953篇 |
1994年 | 1755篇 |
1993年 | 1655篇 |
1992年 | 1208篇 |
1991年 | 1149篇 |
1990年 | 1053篇 |
1989年 | 952篇 |
1988年 | 1011篇 |
1987年 | 1018篇 |
1986年 | 998篇 |
1985年 | 1081篇 |
1984年 | 1478篇 |
1983年 | 1461篇 |
1982年 | 1814篇 |
1981年 | 1639篇 |
1980年 | 1555篇 |
1979年 | 812篇 |
1978年 | 958篇 |
1977年 | 932篇 |
1976年 | 831篇 |
1975年 | 682篇 |
1974年 | 666篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
41.
John A. Robertson 《The Hastings Center report》1991,21(6):6-9
Advance directives such as living wills are attractive in that they give us a sense of control over our futures. But they also tend to obscure conflicts between a patient's competent wishes and later, incompetent interests. They allow caregivers to avoid evaluating quality of life in assessing the best interests of incompetent patients. 相似文献
42.
Reactive oxygen species: a breath of life or death? 总被引:7,自引:0,他引:7
New insights into cancer cell-specific biological pathways are urgently needed to promote development of rationally targeted therapeutics. Reactive oxygen species (ROS) and their role in cancer cell response to growth factor signaling and hypoxia are emerging as verdant areas of exploration on the road to discovering cancer's Achilles heel. One of the distinguishing and near-universal hallmarks of cancer growth is hypoxia. Unregulated cellular proliferation leads to formation of cellular masses that extend beyond the resting vasculature, resulting in oxygen and nutrient deprivation. The resulting hypoxia triggers a number of critical adaptations that enable cancer cell survival, including apoptosis suppression, altered glucose metabolism, and an angiogenic phenotype. Ironically, recent investigations suggest that oxygen depletion stimulates mitochondria to elaborate increased ROS, with subsequent activation of signaling pathways, such as hypoxia inducible factor 1alpha, that promote cancer cell survival and tumor growth. Because mitochondria are key organelles involved in chemotherapy-induced apoptosis induction, the relationship between mitochondria, ROS signaling, and activation of survival pathways under hypoxic conditions has been the subject of increased study. Insights into mechanisms involved in ROS signaling may offer novel avenues to facilitate discovery of cancer-specific therapies. Preclinical and clinical evaluation of agents that modify ROS signaling in cancer offers a novel avenue for intervention. This review will cover recent work in ROS-mediated signaling in cancer cells and its potential as a target for developmental therapeutics. 相似文献
43.
44.
45.
46.
47.
John P Elliott Hugh S Miller Suzanne Coleman Debbie Rhea Diana Abril Karen Hallbauer Niki B Istwan Gary J Stanziano 《Journal of perinatology》2005,25(10):626-630
OBJECTIVE: To assess the impact of activity restriction (AR) on the incidence of preterm birth in women treated for preterm labor testing negative for fetal fibronectin (fFN). STUDY DESIGN: Women who were diagnosed with preterm labor and tocolyzed with magnesium sulfate were concurrently screened with fFN for the purpose of subsequent management. Included were consenting patients with negative fFN, gestational age 23 0/7-33 6/7 weeks, cervical dilation < or =3 cm, and minimal vaginal bleeding. Patients were randomized to AR or no AR. Primary study outcome was incidence of preterm delivery and interval from randomization to delivery. RESULTS: A total of 73 women with negative fFN were randomized (36 with AR, 37 without AR). The overall preterm birth rate was 40%, with 44.4% of patients with AR and 35.1% of patients without AR delivering preterm, p=0.478. CONCLUSION: Maternal AR did not impact pregnancy outcome. The incidence of preterm birth in symptomatic women testing fFN negative was higher than previously reported. 相似文献
48.
49.
50.